Sukhwinder Singh Rai - 15 Nov 2022 Form 3/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role: Director
Signature: /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol: SKYE
Transactions as of: 15 Nov 2022
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 15 Nov 2022, 14:46:30 UTC
Date Of Original Report: 15 Nov 2022
Previous filing: 15 Nov 2022
Next filing: 09 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney